KCNK9

Chr 8AD

potassium two pore domain channel subfamily K member 9

The protein functions as a pH-dependent potassium channel that regulates neuronal excitability by conducting voltage-dependent outward currents and controlling action potential firing in various brain regions including cerebellum and hippocampus. Mutations cause Birk-Barel syndrome, inherited in an autosomal dominant pattern. The gene is highly constrained against loss-of-function variants and shows imprinted expression in the brain with preferential maternal allele expression.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
DNmechanismADLOEUF 0.311 OMIM phenotype
Clinical SummaryKCNK9
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.96). One damaged copy is likely sufficient to cause disease.
📖
GeneReview available — KCNK9
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.31LOEUF
pLI 0.955
Z-score 2.89
OE 0.00 (0.000.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.90Z-score
OE missense 0.48 (0.410.56)
118 obs / 246.2 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.00 (0.000.31)
00.351.4
Missense OE0.48 (0.410.56)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 0 / 9.7Missense obs/exp: 118 / 246.2Syn Z: -0.84
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedKCNK9-related Birk-Barel syndromeDNAD
DN
0.6841th %ile
GOF
0.83top 10%
LOF
0.4627th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative, gain-of-function and loss-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median
LOFLOEUF 0.31

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNFurthermore, expression of dominant-negative mutant KCNK9, responsible for the disease, and electrophysiological experiments demonstrated that ion channel function was involved in the migration defect. Calcium imaging revealed that KCNK9 knockdown or expression of dominant-negative mutant KCNK9 incrPMID:23236211

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

KCNK9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC